US Patent 7491826 Compounds, compositions and methods
Patent 7491826 was granted and assigned to Cytokinetics on February, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Adam Lewis Tomasi0
Alex Muci0
Bradley Paul Morgan0
David J. Morgans, Jr.0
Erica Anne Kraynack0
Fady Malik0
Kathleen A. Elias0
Pu-Ping Lu0
Todd Tochimoto0
Whitney Walter Smith0
Xiangping Qian0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+233 characters)
Article
Patent abstract
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07491826 Compounds, compositions and methods US Patent 7491826 Compounds, compositions and methods
Infobox
Patent Number
07491826
Patent Number
7491826
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07491826 Compounds, compositions and methods
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07491826
Date of patent
February 17, 2009
Patent application number
10890829
Date Filed
July 14, 2004
Patent primary examiner
Find more entities like US Patent 7491826 Compounds, compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
